For the complete report, get in touch with us at : info@netscribes.com
Stericat Gutstrings Pvt. Ltd. is headquartered in Gurgaon and manufactures and markets sutures and suture needles.
The report begins with the basic facts about the company such as contact details, revenues, competitors, brief history, line of business and geographic reach among others. Key Products and Services of the company describes the rationale of how it creates, delivers, and captures value through its products and services offered Information about the company’s management side is also provided that details their names, designation, professional experiences, memberships of boards etc. Through SWOT analysis, the report highlights key internal factors that give the company advantage or disadvantage over its peers along with key external factors prevailing in the industry that may have favorable or unfavorable impact on the company’s operations. The report also covers the financial analysis of the company including the balance sheet profit and loss a/c and the key ratios depicting the key financial figures for fiscal years 2008-11,
Industry Analysis provides top level understanding of the Medical Equipment sector in India with special reference to Surgical Instruments segment. Market size, growth, key segments, growth drivers, import \ export and trends are some of the foremost points covered in the analysis. The competitive landscape identifies key players of the industry drawing comparisons on parameters such financial performance and service offerings. The company is benchmarked against its main competitors’ key financial ratios in the competitive benchmarking chapter.
3. Executive Summary
Company • Stericat Gutstrings (P) Ltd. D and W Y and J and is headquartered in M
Description • The company started its business in collaboration with a B company in India
Key Products and • Stericat manufactures a whole range of D as per the O and P standards. It also manufactures products
under segments of M, N and C
Services
• Strength 1 is one of the major strengths of the company; however Weakness 1 is one of the key areas of
concern
SWOT Analysis • The company can reap significant benefits owing to opportunity 1 while Threat 1 may have an adverse
affect on the strategic initiatives and growth prospects of the organization
• Stericat Gutstrings (P) Ltd. generated total income of INR W mn in FY 20‐‐, registering a y‐o‐y increase of c
per cent. The company earned a net profit of INR X mn in FY 20‐‐, with an increase of s per cent over FY 20‐
‐
Financial Profile • The financial profile of the company includes the balance sheet, profit and loss a/c and the key ratios
depicting the key financial figures for FY 20‐‐, 20‐‐, 20‐‐ and 20‐‐, giving an insight into the company's
financial performance
• Medical Equipments market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per
cent to reach INR B bn in FY 20‐‐
• The Medical Equipments market is classified into segments such as P, Q, R and S
Industry Analysis • The Surgical Instruments market in India is estimated at INR A bn in FY 20‐‐ and is expected to grow at a
CAGR of x per cent to reach INR B bn by FY 20‐‐
• The key drivers are A, B, C and D
Competitive • Key competitors for the company can be enlisted as: Competitor 1 and Competitor 2
Landscape
3
4. Factsheet
Basic Information Brief Description
Industry Healthcare – Surgical Devices • Stericat Gutstrings (P) Ltd. (Stericat) manufactures and markets
R and Y.
Corporate Address ‐
• The company adheres to quality standards such as:
‐‐
‐‐
‐‐
‐‐
Tel No. ‐
• Stericat manufactures a whole range of D as per the O and P
Fax No. ‐ standards. It also manufactures products under segments of M,
N and C
Website ‐ • The company has an in house V approved by the Y to conduct O,
E
P and F tests as per U
Year Founded ‐
PL
• It provides training to its T on various aspects of B. Also Z are
Year of Incorporation ‐
AM
conducted at regular interval to improve the Q and R of the H
S
Ownership ‐
Revenue ‐
Fiscal Year End ‐
Auditor ‐
Key Competitors ‐
Brief History
• 19‐‐:
Source:
4
7. Key People
Shareholders of the Company Key Executives
Name No. of Shares Held
Date of
Name Designation Age (years)
Appointment
‐ ‐
‐ ‐
‐ ‐ ‐ ‐
‐ ‐
‐ ‐ ‐ ‐ ‐ ‐
‐ ‐
‐
SAMPLE ‐
‐ ‐ ‐ ‐
Ownership Structure Shareholding Pattern
G
Total Paid‐up Capital INR D
Total Number of shareholders ‐ a%
Note:
Source:
7
10. Financial Profile
Financial Snapshot Profit & Loss Statement
Total Income
Particulars 2008 2009 2010 2011
Net Income
INR mn Operating
‐ ‐ ‐ ‐
Income
140
B M
120 Other Income ‐ ‐ ‐ ‐
W N
100 Total Income ‐ ‐ ‐ ‐
80 Expenditure
‐ ‐ ‐ ‐
60 (below)
40 Operating
‐ ‐ ‐ ‐
20 O expenses
Y P K
0 Administrative
20‐‐ 20‐‐ 20‐‐ 20‐‐ ‐ ‐ ‐ ‐
Expenses
Financial Summary Depreciation ‐ ‐ ‐ ‐
Other Expenses ‐ ‐ ‐ ‐
• Analysis point 1
analysis point 2 Total
‐ ‐ ‐ ‐
LE
Expenditure
MP
• Analysis point 3
Profit/(Loss)
SA
‐ ‐ ‐ ‐
before Tax
Profit/(Loss)
‐ ‐ ‐ ‐
after Tax
Source: Note:
10
11. Ratio Analysis
Key Ratios Key Ratio Analysis
y‐o‐y
Particulars change 2011 2010 2009 2008 • Analysis point 1
(2011‐10)
Profitability Ratios • Analysis point 2
Operating Margin ‐ ‐ ‐ ‐ ‐
Net Margin ‐ ‐ ‐ ‐ ‐ • Analysis point 3
Profit Before Tax Margin ‐ ‐ ‐ ‐ ‐
Return on Equity ‐ ‐ ‐ ‐ ‐ • Analysis point 4
Return on Capital Employed ‐ ‐ ‐ ‐ ‐
E
Return on Working Capital ‐ ‐ ‐ ‐ ‐ • Analysis point 5
PL
Return on Assets ‐ ‐ ‐ ‐ ‐
Return on Fixed Assets ‐ ‐ ‐ ‐ ‐ • Analysis point 6
AM
Cost Ratios ‐ ‐ ‐ ‐ ‐
S
Operating costs (% of Sales) ‐ ‐ ‐ ‐ ‐ • Analysis point 7
Administrative Costs (% of Sales) ‐ ‐ ‐ ‐ ‐
Liquidity Ratios ‐ ‐ ‐ ‐ ‐
Current Ratio ‐ ‐ ‐ ‐ ‐
Cash Ratio ‐ ‐ ‐ ‐ ‐
Leverage Ratios ‐ ‐ ‐ ‐ ‐
Debt to Equity Ratio ‐ ‐ ‐ ‐ ‐
Debt to Capital Ratio ‐ ‐ ‐ ‐ ‐
Efficiency Ratios ‐ ‐ ‐ ‐ ‐
Fixed Asset Turnover ‐ ‐ ‐ ‐ ‐
Asset Turnover ‐ ‐ ‐ ‐ ‐
Current Asset Turnover ‐ ‐ ‐ ‐ ‐
Working Capital Turnover ‐ ‐ ‐ ‐ ‐
Capital Employed Turnover ‐ ‐ ‐ ‐ ‐ Note:
Source: Improved Decline
11
13. Industry Analysis
Medical Equipment Industry – Overview Market Size & Growth (20‐‐ ‐20‐‐e)
• The Medical Equipment market is estimated at INR A bn in FY
20‐‐ and expected to grow at a CAGR of x per cent to reach INR B INR bn
bn by FY 20‐‐
100 G
• This market can be classified into segments such as C, D, E and F x% F
• Indian medical equipment market imports y per cent of its 80 E
medical equipments from countries such as M, N, O, P D
60 C
B
• Major trends observed in the medical equipment market are:
A
40
LE
Trend 1
Trend 2
Trend 3 20
Trend 4
M
Trend 5
P
• Some of the key drivers of the medical equipment market are:
0
20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e 20‐‐e
SA
Driver 1
Driver 2
Driver 3
Market Segmentation (FY 20‐‐)
Driver 4
Driver 5 a%
• Some of the Government initiatives towards the Medical d%
equipment market were: M
Point 1 N
Point 2 O
b% P
c%
Source:
13
14. Industry Analysis
Surgical Instruments Market – Overview Market Size & Growth (20‐‐ ‐20‐‐e)
• The Surgical Instruments market in India is estimated at INR A bn INR bn
25 U
in FY 20‐‐ and is expected to grow at a CAGR of x per cent to x%
20 T
reach INR B bn by FY 20— S
15 R
Q
P
10
• Surgical Instruments is a part of the X
5
0
• Some of the key drivers of the surgical instruments market are:
E
20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e
PL
‐‐ Import ‐ Export Pattern of Major Surgical
AM
Instruments
‐‐
‐‐
‐‐
S INR mn
3,000
2,000
A
B
C
D
E
Imports
F
G
Exports
H
• Some of the major trends are: 1,000
A 0
20-- 20-- 20-- 20--
12%
B HS Code 49%
HS Code Description
‐‐ ‐‐
C ‐‐ ‐‐
‐‐ ‐‐
‐‐ ‐‐
‐‐ ‐‐
‐‐ ‐‐
Source:
14
15. Competitive Landscape (1/2)
Company Name Description
Company 1 • ‐‐
• ‐‐
• ‐‐
Company 2 ‐‐
‐‐
‐‐
E
‐‐
S AMPL
Source:
15
16. Competitive Landscape (2/2)
Competitive Scenario
Company Name Company 1 Company 2 Company 3
Financial Information (INR mn – FY 2011)
Total Revenue ‐ ‐ ‐
Net Profit/(loss) ‐ ‐ ‐
Major Market Segmentation (Surgical Instruments)
Surgical Instruments
Sutures Suture Needles
Cannulas
PL E
Forceps
AM
Scissors
S
Retractors
Catheters
Blades
Knives
Scalpel
Hospital Equipment
Source: H: High; L: Low; M: Medium Offered Not Offered
16
17. Competitive Benchmarking
Key Financial Ratios – FY 2011
% W
20 J
15 • Analysis point 1
10 H
• Analysis point 2
5
0
Z X
G H T
5
4
E
• Analysis point 3
3 N
PL
• Analysis point 4
2
Y • Analysis point 5
B E
AM
1 R
S
0
Z X V
P U
I
0.6
• Analysis point 6
O
0.4 • Analysis point 7
0.2 E R • Analysis point 8
T Y
0.0
Z X V
Source:
17
18. Thank you for the attention
Stericat Gutstrings (P) Ltd. is a part of Netscribes’ Healthcare Company Profile Series.
For more detailed information or customized research requirements please contact:
Jitendra Punjabi
Phone: +91 33 4064 6215
E‐Mail: jitendra.punjabi@netscribes.com
About Netscribes
Netscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment
& business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a
true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and
growth objectives.
This report is published for general information only. Although high standards have been used in preparing this report, Netscribes (India) Pvt.
Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes
(India) Pvt. Ltd. and no part may be reproduced without prior written permission.
www.netscribes.com
18